Hb Wealth Management, LLC Celularity Inc Transaction History

Hb Wealth Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 16, 2024	SELL	$0.17 - $0.33 $21,675 - $42,075	-127,500 Reduced 68.0%	60,000 $15,000
Q3 2023 Oct 13, 2023	BUY	$0.22 - $0.56 $11,000 - $28,000	50,000 Added 36.36%	187,500 $41,000
Q2 2023 Jul 13, 2023	BUY	$0.42 - $0.81 $12,019 - $23,180	28,618 Added 26.28%	137,500 $72,000
Q1 2023 Apr 13, 2023	BUY	$0.56 - $1.15 $12,588 - $25,851	22,480 Added 26.02%	108,882 $67,000
Q4 2022 Jan 20, 2023	BUY	$1.08 - $2.35 $27,021 - $58,797	25,020 Added 40.76%	86,402 $0
Q2 2022 Jul 15, 2022	BUY	$2.81 - $12.91 $86,056 - $395,368	30,625 Added 99.57%	61,382 $209,000
Q1 2022 May 16, 2022	BUY	$3.81 - $9.79 $34,343 - $88,247	9,014 Added 41.46%	30,757 $268,000
Q4 2021 Feb 15, 2022	BUY	$4.64 - $7.46 $100,887 - $162,202	21,743 New	21,743 $111,000

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $319M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Hb Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Hb Wealth Management, LLC with notifications on news.